BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 5.08.1997

Bio-Components, Inc.; Revocation of U.S. License No. 1160

The Food and Drug Administration (FDA) is announcing the revocation of U.S. License No. 1160, which includes the establishment license and the product licenses for the manufacture of Source Plasma and Source Leukocytes, issued to Bio-Components, Inc. (BCI). BCI did not respond to a notice of opportunity for a hearing on a proposal to revoke its licenses.

Source: Federal Register — Food and Drug AdministrationOpen original release →